Trial Profile
Phase I Trial of Aflibercept (VEGF Trap) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Malignant Glioma
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary) ; Temozolomide
- Indications Anaplastic astrocytoma; Glioblastoma; Glioma
- Focus Adverse reactions
- 21 May 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 25 May 2012 Actual patinent number is 60 as reported by ClinicalTrials.gov.
- 27 Jun 2011 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.